Advanced Enzyme Technologies Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ADVENZYMES BSE: 540025

₹281.60

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #70 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Advanced Enzyme Technologies Limited (this stock)	3,153	39.3	10.3%	-15.1%	—	66	41	11

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹3,151 Cr

EV / EBITDA

26.6x

EV / Sales

7.10x

Market cap / Sales

7.11x

Earnings yield

2.54%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 118 Cr, down 34.0% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 22 Cr, down 69.8% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	116	30	22	₹2.0000
March 31, 2026	116	29	22	₹1.9900
Dec. 31, 2025	96	18	13	₹1.1800
Sept. 30, 2025	116	30	22	₹1.9900
June 30, 2025	125	81	74	₹6.6100
March 31, 2025	87	16	11	₹0.9900
Dec. 31, 2024	101	21	15	₹1.3600
Sept. 30, 2024	77	12	9	₹0.8200
June 30, 2024	86	72	67	₹6.0000
March 31, 2024	92	10	3	₹0.2800
Dec. 31, 2023	91	25	19	₹
Sept. 30, 2023	97	25	18	₹1.6400
June 30, 2023	85	73	67	₹6.0400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	118	122	97	119	179	92	102	79	140	96	97	137	85
Operating revenue	116	116	96	116	125	87	101	77	86	92	97	85	83
Other income	2	5	1	3	54	5	1	2	54	3	1	51	3
Operating expenses	85	90	72	86	94	73	79	64	65	63	70	61	59
Operating profit	30	27	23	30	31	14	22	14	21	29	27	25	23
Operating profit margin	26.2%	23.1%	24.5%	25.6%	24.4%	16.2%	21.9%	17.5%	24.3%	31.6%	27.6%	29.0%	28.2%
Depreciation	3	3	3	3	3	3	3	3	3	3	3	3	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	-4	—	—	—	—	—	—	-19	—	—	—
Profit before tax	30	29	18	30	81	16	21	12	72	10	25	73	23
Tax	7	7	5	7	7	4	5	3	5	7	6	6	6
Net profit	22	22	13	22	74	11	15	9	67	3	18	67	17
EPS	2.00	1.99	1.18	1.99	6.61	0.99	1.36	0.82	6.00	0.28	1.64	6.04	1.56
Net profit (TTM)	80	132	121	123	109	102	95	98	156	106	120	115	56
EPS (TTM)	7.16	11.77	10.77	10.95	9.78	9.17	8.46	8.74	13.96	9.52	10.73	10.31	4.97

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	453	158	132
March 31, 2025	351	121	102
March 31, 2024	365	134	108
March 31, 2023	312	74	56

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Total income (before exceptional items)	17.1%	12.2%	516^†	413^†	—	321^†	282^†	290^†	256^†	228^†	220^†
Operating revenue	13.3%	9.8%	453	351	365	312	273^†	283^†	247^†	222^†	215^†
Other income	—	—	63^†	61^†	—	10^†	9^†	7^†	9^†	6^†	5^†
Operating expenses	—	—	342^†	281^†	—	237^†	200^†	183^†	171^†	168^†	165^†
Operating profit	13.8%	1.9%	110^†	71^†	—	75^†	73^†	101^†	77^†	54^†	50^†
Operating profit margin	—	—	24.4%^†	20.1%^†	—	24.0%^†	26.6%^†	35.5%^†	31.0%^†	24.4%^†	23.1%^†
Depreciation	—	—	12^†	11^†	—	10^†	10^†	9^†	9^†	9^†	8^†
Interest	—	—	0^†	0^†	—	0^†	0^†	0^†	1^†	4^†	3^†
Exceptional items, gain / (loss)	—	—	-4^†	0^†	—	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	28.5%	9.9%	158	121	134	74	72^†	98^†	76^†	47^†	44^†
Tax	—	—	26^†	18^†	—	19^†	18^†	27^†	18^†	12^†	8^†
Net profit	33.4%	13.2%	132	102	108	56	55^†	71^†	58^†	35^†	36^†
EPS	33.3%	13.1%	11.77^†	9.17^†	—	4.97^†	4.87^†	6.36^†	5.19^†	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Operating margin	24.4%^†	20.1%^†	—	24.0%^†	26.6%^†	35.5%^†	31.0%^†	24.4%^†	23.1%^†
EBIT margin	34.9%^†	34.4%^†	—	23.9%^†	26.5%^†	34.8%^†	31.1%^†	23.0%^†	21.9%^†
PBT margin	34.8%	34.3%	36.7%	23.8%	26.4%^†	34.7%^†	30.7%^†	21.3%^†	20.4%^†
Net margin	29.1%	29.1%	29.6%	17.8%	20.0%^†	25.1%^†	23.4%^†	15.9%^†	16.7%^†
Interest coverage	762.71x^†	511.71x^†	—	551.21x^†	759.65x^†	1172.76x^†	69.96x^†	13.01x^†	14.28x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	4.06x	5.19x	—	—	—	—	—	—	—
Quick ratio	2.56x	2.92x	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—
Return on equity	18.6%	16.3%	—	—	—	—	—	—	—
Return on assets	16.4%	14.9%	—	—	—	—	—	—	—
Return on capital employed	21.8%^†	18.8%^†	—	—	—	—	—	—	—
Asset turnover	0.56x	0.51x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	89	-34	-58	44	44
March 31, 2025	63	-2	-58	22	41
March 31, 2024	56	-7	-57	0	56
March 31, 2023	50	-42	-12	23	27
March 31, 2022	37	-14	-11	11	27

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	804	710	687	0	0	316	78	2	145	117
March 31, 2025	689	629	607	0	0	232	45	6	151	101
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.